Greg Widseth, a 47-year old Polk County attorney, was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that Widseth had antibodies known to target certain brain cells. Read the full article to learn more about autoimmune disorder testing and treatment.
Recent Stories for News
Fewer than five percent of people who die in hospitals are autopsied today. Autopsies are beneficial to discovering new advances in diseases, including cancer, dementia, and heart disease. In an article in the Wall Street Journal, Joseph Maleszewski, a cardiovascular pathologist at the Mayo Clinic in Rochester, Minn., discusses how “molecular autopsies” can provide useful information about a patient’s genetics.
Mayo Clinic Evacuation Project Team Employs Six Sigma Methodology to Emergency Preparedness Procedures
In June 2013, Mayo Clinic’s Hilton-11 project team began work to develop new safety processes to enhance employees’ preparedness and overall safety. The project team successfully used the Six Sigma DMAIC problem-solving methodology (define-measure-analyze-improve-control) to manage and improve its existing Emergency Preparedness Plan (EPP).
Other Posts for News
- Mayo Clinic Releases PathWays: New Online “Case Study” Tool for Pathologists and Medical Enthusiasts
- Mayo Medical Laboratories and Seattle Children’s Hospital Partner in Effort to Lower Costs of Clinical Laboratory Tests
- US Senator Amy Klobuchar to Tour Mayo Clinic Biobank and Discuss Precision Medicine Initiative
- William Morice, M.D., Ph.D., Discusses Value From Laboratory Test Data at FiLM Conference
- Applying Toyota’s Lean Production System in Healthcare and Hospitals
- MicrobeWatch: Jan. 5 Influenza Update
- Mid-America Service Solutions Selects Mayo Medical Laboratories for Reference Laboratory Services
- Keys to a Healthier 2015
- Courier and Carrier Schedules for the Holidays
- Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening